US 9820951
Pulmonary disease treatment and diagnosis based on Arhgef1
granted A61KA61K31/18A61K31/192
Quick answer
US patent 9820951 (Pulmonary disease treatment and diagnosis based on Arhgef1) held by The Regents of the University of Colorado, a Body Corporate expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/18, A61K31/192, A61K31/403, A61K31/4178